# OPTIMIST-A Trial: Minimally-invasive Surfactant Therapy in Preterm Infants 25-28 Weeks Gestation on CPAP

> **NCT02140580** · PHASE4 · UNKNOWN · sponsor: **Menzies Institute for Medical Research** · enrollment: 486 (actual)

## Conditions studied

- Bronchopulmonary Dysplasia

## Interventions

- **DEVICE:** Minimally invasive surfactant therapy
- **OTHER:** Continuation on CPAP

## Key facts

- **NCT ID:** NCT02140580
- **Lead sponsor:** Menzies Institute for Medical Research
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-12
- **Primary completion:** 2020-05
- **Final completion:** 2022-06
- **Target enrollment:** 486 (ACTUAL)
- **Last updated:** 2020-05-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02140580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02140580, "OPTIMIST-A Trial: Minimally-invasive Surfactant Therapy in Preterm Infants 25-28 Weeks Gestation on CPAP". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02140580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*